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Significance	of	underlying	pathophysiology	
• PKD	is	an	inherited	disease	and	makes	up	for	8-10%	of		
Popula:on	with	ESRD		(Silverman,	2015).	
• PKD	is	a	systemic	disorder	that	causes	irreversible	kidney	func:on,	and	can	cause	cyst	forma:on	
in	the	liver,	pancreas,	brain,	and	arteries	(Silverman,	2015).	
• Cyst	can	cause	urinary	tract	infec:ons,	flank	pain,	lead	to	ESRD	and	if	external	cyst	exist	serious	
complica:ons	such	as	ruptured	cerebral	aneurysm	can	occur	(Silverman,	2015).	
• 	Eventually	the	disease	will	progress	that	renal	replacement	therapy	of	dialysis	 is	needed	and	
kidney	tranpla:on	(Silverman,	2015).	
Polycys6c	Kidney	Disease	
Caitlin	Byrne,	BSN-RN		
Presenta6on	of	case	or	process	
Sam	a	42	year	old	female	 	is	concerned	with	her	diagnosis	of	PKD.	Sam’s	mother	and	
older	sister	both	have	PKD	and	have	each	received	kidney	transplants.	Due	to	family	
gene:cs,	 Sam	had	 gene:c	 tes:ng	 and	 an	 ultrasound	performed	 at	 the	 age	 of	 18	 to	
determine	 if	 she	 also	 had	 PKD,	 in	which	 cysts	were	 found	 to	 confirm	her	 diagnosis.	
Sam	has	been	symptom	free	un:l	four	months	ago	in	which	she	has	had	mul:ple	UTI’s	
and	severe	flank	pain.	Sam	went	to	see	her	PCP,	where	labs	were	drawn	and	another	
ultrasound	performed.	Sams	crea:nine	level	came	back	7mg/dL	(normal	0.6-1.2	mg/dL	
(McCance	&	Huether,	2018).	Along	with	mul:ple	cyst	and	an	enlarged	kidney	found	on	
her	 renal	ultrasound.	Sam	began	at	home	dialysis	and	was	placed	on	 the	 the	kidney	
transplant	list.	Sam	was	also	monitored	for	other	complica:ons	such	as	hypertension	
and	cardiac	disease,	she	had	frequent	 	visits	to	her	PCP	and	nephrologist	to	monitor	
her	 kidney	 func:on.	 Sam	finally	 received	a	 kidney	 transplant,	 she	 is	 now	off	dialysis	
and	her	crea:nine	is	normal.		
Signs	and	Symptoms.	
• 	very	few	symptoms-some	people	experience	no	symptoms	at	all		
• Abdmoinal	pain/flank	pain	is	most	common	
• Hypertension	
• Palpable	kidneys	
• Hematuria	
• Frequent	UTI’s	
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Introduc6on	
	 Autosomal	 dominant	 polycys:c	 kidney	 disease	 (ADPKD)	 and	 autosomal	 recessive	
kidney	 disease	 (ARPKD)	 are	 two	 forms	 of	 polycys:c	 kidney	 disease	 (PKD)	 	 and	 are	
leading	causes	of	end	stage	renal	disease	(ESRD)	(Silverman,	2015).	PKD	can	affect	both	
children	 and	 adults	 and	 is	 one	 of	 the	most	 common	 hereditary	 disorders	 (Silverman,	
2015).	PKD	can	 lead	to	other	medical	complica:ons	 like	hypertension,	cardiac	disease,	
and	cerebral	aneurysm	(Silverman,	2015).	In	PKD	there	is	forma:on	of	renal	cyst,	though	
cyst	can	also	form	on	the	liver,	pancreas,	spleen,	thyroid,	arteries	and	brain	(Silverman,	
2015).	There	is	no	cure	currently	for	PKD,	though	treatments	for	symptoms,	secondary	
medical	condi:ons,	undergoing	dialysis	and	kidney	transplants	are	used	to	manage	the	
disease	(Silverman,	2015).	
	 	 	 	 	This	author	currently	works	at	Riverside	Methodist	hospital	on	a	stroke	unit,	where	
PKD	is	an	uncommon	diagnosis.	Recently	a	close	family	friend	received	the	diagnosis	of	
PKD	 and	 had	 to	 undergo	 a	 kidney	 transplant.	With	 this	 friend’s	 diagnosis	 and	 lack	 of	
exposure	 to	 pa:ents	with	 PKD,	 this	 author	 chose	 PKD	 to	 become	more	 familiar,	 gain	
knowledge	and	be_er	care	for	pa:ents	with	PKD.		 Nursing	Implica6ons	
• Obtain	a	complete	medical	history	and	full	body	assessment	
• Encourage	 low-salt	 diet,	 high	water	 intake,	 and	 exercise	 (Tran	 et	 al.,	
2017).	
• Monitor	 blood	 pressure	 and	 provide	 medica:ons	 like	 ACE	 inhibitors	
for	blood	pressure	management	(Tran	et	al.,	2017).	
• Symptom	management	 /	 pain	 control	 including	 an:bio:cs	 for	 UTI’s,	
and	bed	rest	for	gross	hematuria	(Silverman,	2015).	
• Close	monitoring,	lab	draws,	and	urinalysis	for	kidney	func:on.	
• Provide	educa:on/	prepara:on	for	renal	replacement	therapy.	
• Provide	gene:c	counseling	for	pa:ents	with	children.		
Underlying	Pathophysiology	
• The	 gene	 products,	 polycys:n-1	 and	 polycys:n-2,	 encoded	 on	 the	 genes	 PKD-1	 and	 PKD-2,	 regulate	
growth	and	mechanosensory	ac:ons	in	the	renal	tubular	cilia	(Po_s	&	Mousa,	2017).		
• Muta:ons	of	gene	PKD-1	occur	on	chromosome	16	and	PKD-2	on	chromosome	4	(Silverman,	2015).	
• Muta:ons	 cause	 defects	 in	 epithelial	 cells	 and	 cilium	 leading	 to	 cyst	 forma:on,	 obstruc:on,	 and	
destruc:on	of	renal	parenchyma,	inters::al	fibrosis,	and	loss	of	func:onal	nephrons		(McCance	&	Huether,	
2018).		
• Most	muta:ons	of	these	genes	are	caused	by	nonsense,	frameshia,	or	splice	in	site	altera:ons	(Silverman,	
2015).	
Conclusion	
			PKD	is	a	serious	gene:c	disease	and	a	leading	cause	of	ESRD		(Po_s	&	Mousa,	2017).	Providing	
suppor:ve	care	and	symptom	management	is	extremely	important	throughout	the	progression	
of	 the	disease.	Gene:c	counseling	 for	 families	with	PKD	can	help	 iden:fy	and	prepare	 for	 the	
progression	 and	 complica:ons	 PKD	 entails.	 Medica:ons,	 renal	 	 replacement	 therapies,	 and	
kidney	transplants	help	slow	disease	progression	and	provide	disease	treatment,	though	no	cure	
currently	 exists.	 Throughout	 these	 treaments	 it	 is	 important	 for	 health	 care	 provides	 to	 be	
suppor:ve	and	encouragement	to	all	PKD	pa:ents.		
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